Cigna says it is not pursuing deal with rival Humana, shares jump

By Sriparna Roy and Mariam Sunny

(Reuters) - Cigna (NYSE:CI ) Group is not pursuing a combination with rival Humana (NYSE:HUM ), the health insurer said on Monday (NASDAQ:MNDY ), days after Donald Trump's re-election as U.S. president raised investor hopes that the reported merger may pass antitrust scrutiny.

Shares of Humana have gained nearly 13% and Cigna rose more than 2% since last week on increasing bets over an easier antitrust review for the mega-merger.

Cigna's stock rose nearly 8% in premarket trading, after the company said it "remains committed to its established M&A criteria and would only consider acquisitions that are strategically aligned, financially attractive and have a high probability to close".

Humana, whose shares fell more than 5% before the bell, did not immediately respond to a Reuters request for comment.

Morningstar analyst Julie Utterback called Cigna's announcement as "unusual" and said the move was aimed at removing pressure on its stock.

"With the Republican win last week, there was speculation by investors that the antitrust concerns may decline enough to make the deal possible," Utterback said.

Cigna said it was making the announcement ahead of meetings with investors and analysts over the next several weeks.

Bloomberg News reported in October that Cigna had revived efforts to merge with Humana. That came after Reuters reported last year that Cigna had ended its attempt to negotiate an acquisition after the pair failed to agree on a price.

Cigna, mainly dealing with employer-sponsored healthcare plans, is in the process of selling its Medicare Advantage business, which manages government-backed health insurance for people aged 65 and older.

Medicare-focused insurers such as Humana have been under pressure due to high medical costs in providing the plans as older adults seek healthcare services.

Last month, Cigna CEO David Cordani described the Medicare Advantage market as highly disrupted and said the company was focused on share buybacks.



The company said on Monday it expects to actively repurchase shares in the fourth quarter and in 2025.



(This story has been refiled to change the image with no changes to text)

Source: Investing.com

Последние публикации
BYD says it sets negotiable price cut targets for suppliers
27.11.2024 - 07:00
Australia stocks higher at close of trade; S&P/ASX 200 up 0.57%
27.11.2024 - 07:00
OpenAI allows employees to sell $1.5 billion stock to SoftBank, CNBC reports
27.11.2024 - 07:00
OpenAI employees to sell $1.5 bln in shares to SoftBank- CNBC
27.11.2024 - 07:00
Asia stocks drift lower; Chinese shares defy Trump tariff threats
27.11.2024 - 06:00
China's BYD sets negotiable price reduction targets for suppliers
27.11.2024 - 06:00
FAA will not require immediate 737 MAX engine action after bird strikes
27.11.2024 - 06:00
Australia moves closer to ban social media for children
27.11.2024 - 06:00
Turkey scales down $23 billion F-16 jet deal with US, minister says
27.11.2024 - 06:00
Taiwan's Foxconn says global manufacturing footprint to shield it from Trump's tariffs
27.11.2024 - 05:00
Trump taps Kevin Hassett to head National Economic Council
27.11.2024 - 04:00
Hyundai Motor to buy back $716 million worth of shares
27.11.2024 - 04:00
Trump tariffs could hurt S&P 500 earnings by ‘few percentage points’- Citi
27.11.2024 - 04:00
Hyundai Motor: Morgan Stanley Overweight, sees resilience against US tariffs
27.11.2024 - 03:00
China courier group S.F. Holding's shares open flat in Hong Kong trading debut
27.11.2024 - 03:00

© Analytic DC. All Rights Reserved.

new
Анализ рынка Как повлият завтра отчет NFP на курс доллара США?